Theriva Biologics
TOVX
TOVX
61 hedge funds and large institutions have $64.2M invested in Theriva Biologics in 2016 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 0% → 0% (+0%)
15% less capital invested
Capital invested by funds: $75.5M → $64.2M (-$11.4M)
Holders
61
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.29M | |
| 2 | +$1.48M | |
| 3 | +$1.28M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.12M |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$492K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$987K | |
| 3 | -$898K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$271K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$261K |